International Stem Cell Corporation
ISCO
$0.1457
-$0.0163-10.06%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.98% | 0.00% | 29.49% | 10.44% | 26.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.98% | 0.00% | 29.49% | 10.44% | 26.62% |
| Cost of Revenue | 1.53% | 11.84% | 14.72% | 24.71% | 28.05% |
| Gross Profit | 7.19% | -8.45% | 41.91% | 1.09% | 25.71% |
| SG&A Expenses | 0.42% | -6.28% | -5.16% | -2.29% | -8.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.49% | 1.60% | 3.55% | 9.61% | 9.92% |
| Operating Income | 12.08% | -20.79% | 112.03% | 7.22% | 203.47% |
| Income Before Tax | 8.40% | -19.63% | 102.40% | 4.58% | -75.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.40% | -19.63% | 102.40% | 4.58% | -75.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.40% | -19.63% | 102.40% | 4.58% | -75.81% |
| EBIT | 12.08% | -20.79% | 112.03% | 7.22% | 203.47% |
| EBITDA | 11.06% | -24.03% | 127.93% | 26.00% | 307.29% |
| EPS Basic | 9.09% | -19.85% | 103.69% | 4.88% | -76.23% |
| Normalized Basic EPS | 8.60% | -19.76% | 102.51% | 3.92% | 169.40% |
| EPS Diluted | 9.09% | -19.85% | 103.69% | 4.88% | -76.23% |
| Normalized Diluted EPS | 8.60% | -19.76% | 102.51% | 3.92% | 169.40% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |